Our observation is well in accordance with the findings on animal models by Markison et al. [30-31] reporting that central application of exogenous AgRP (83-132) or systemic MC4R antagonists can protect against the anorexic effect of LLC (Lewis lung carcinoma) tumors. Here, MC4R is linked to Carcinoma, Lewis Lung.